This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08061/identifier/pubchem-substance/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08061/identifier/drugbank/
n12http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB08061/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08061/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB08061/identifier/pubchem-compound/

Statements

Subject Item
n2:DB08061
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB08061 n12:DB08061
dcterms:title
4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE
adms:identifier
n8:DB08061 n10:L02 n11:395743 n13:449126 n14:99444532
n3:IUPAC-Name
n4:271B5A38-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5A3E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5A3D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5A3A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5A3B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5A3C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5A36-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5A34-363D-11E5-9242-09173F13E4C5 n4:271B5A37-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5A35-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5A44-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5A45-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5A3F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5A40-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5A42-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5A41-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5A43-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5A4A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5A4C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5A4D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5A49-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5A48-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5A4B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5A39-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5A46-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5A47-363D-11E5-9242-09173F13E4C5